You are viewing: Japan Latent TB Testing Market analysis
Part of: Latent TB Testing Market (Global)

The Japan Latent TB Testing Market was valued at $48.51 Million in 2024 and projected to reach to $68.15 Million by 2029, representing a compound annual growth rate of 7.0%. Japan's latent TB testing market is positioned for sustained expansion through 2029, driven by the nation's aging demographic profile and proactive public health initiatives targeting TB elimination.

Japan Latent TB Testing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Japan Latent TB Testing Market Trends and Insights

  • Japan's advanced healthcare infrastructure and aging population drive demand for latent TB diagnostics, as the nation prioritizes tuberculosis screening and prevention programs.
  • The 7.0% compound annual growth rate reflects Japan's commitment to TB elimination and increased adoption of interferon-gamma release assays (IGRAs) and tuberculin skin tests across clinical and occupational health settings. In Japan, latent TB testing is increasingly integrated into routine health screenings, particularly among healthcare workers, immunocompromised patients, and individuals with occupational exposure risks.
  • Japan's regulatory environment and reimbursement policies support market expansion, while technological advancements in diagnostic accuracy enhance clinical adoption.
  • The forecast period (2024-2029) anticipates sustained growth driven by Japan's aging demographic, rising awareness of TB transmission risks, and strengthened public health initiatives aligned with WHO TB elimination targets..

Key Market Statistics

  • CAGR (2024-2029) 7.0% CAGR
  • Market Size, 2024 ~USD 48.51 Million
  • Forecast, 2029 ~USD 68.15 Million
  • Country Japan

Japan Latent TB Testing Market Overview

Market Valuation :

Japan's latent TB testing market is valued at $48.51 million in 2024, with strong growth trajectory reaching $68.15 million by 2029, representing a 7.0% CAGR.

Advanced Healthcare Infrastructure :

Japan's sophisticated healthcare system and high diagnostic adoption rates support widespread implementation of latent TB testing technologies across hospitals, clinics, and screening centers.

Aging Population Demographics :

Japan's rapidly aging population increases susceptibility to TB reactivation, driving heightened demand for latent TB screening and preventive diagnostic solutions among elderly populations.

Government TB Elimination Programs :

Japan's commitment to tuberculosis elimination through national screening initiatives and prevention programs creates sustained demand for reliable latent TB diagnostic testing solutions.

Japan Latent TB Testing Market Dynamics

  • The 7.0% CAGR outpaces the global average of 5.8%, reflecting Japan's prioritization of preventive healthcare and advanced diagnostic capabilities.
  • Healthcare providers are increasingly adopting molecular and immunological testing methods to identify latent TB infections before progression to active disease. Government-backed screening programs and integration of latent TB testing into routine healthcare protocols will continue supporting market growth.
  • Japan's emphasis on early detection, combined with rising healthcare expenditure and technological innovation in diagnostic platforms, positions the market for robust expansion.
  • Strategic partnerships between diagnostic manufacturers and Japanese healthcare institutions will further accelerate market penetration and accessibility across urban and regional healthcare facilities..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Japan's latent TB testing market is valued at $48.51 million in 2024 and is forecast to reach $68.15 million by 2029, representing a 7.0% CAGR.
    • Japan's aging population and advanced healthcare infrastructure create sustained demand for latent TB diagnostics across clinical and occupational health sectors.
    • In Japan, interferon-gamma release assays (IGRAs) and tuberculin skin tests are increasingly adopted as part of routine screening protocols for high-risk populations.
    • Japan's regulatory support and reimbursement policies, combined with TB elimination initiatives, drive market expansion through 2029.

    Latent TB Testing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment HOUSEHOLD CONTACTS WITH PULMONARY TB (Application)
    Forecast Period 2024-2029
    Growth Rate CAGR of 5.8% from 2024 to 2029
    Largest Segment IGRA (Test Type)
    Market Size Base Year (Billions) ~USD 0.58 (2024)
    Revenue Forecast (Billions) ~USD 0.77 (2029)
    Segments Covered Test Type, Application, End User

    Japan Latent TB Testing Market Report Segmentation

    3 segment dimensions are covered across the global market.

    By Test Type

    • Igra
    • Tst

    By Application

    • Household Contacts With Pulmonary Tb
    • Other Applications
    • People Living With Hiv

    By End User

    • Academic & Research Institutes
    • Diagnostic Laboratories
    • Hospitals & Clinics
    • Other End Users

    JAPAN: LATENT TB TESTING MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    ACADEMIC & RESEARCH INSTITUTES2.793.253.343.473.643.844.084.365.4
    DIAGNOSTIC LABORATORIES26.2831.2132.8534.8437.3140.2143.6247.517.7
    HOSPITALS & CLINICS8.539.9710.3310.7811.3612.0512.8613.796
    OTHER END USERS1.691.951.992.052.132.232.352.494.6
    TOTAL39.346.3748.5151.1454.4458.3362.9268.157

    Target Audience

    • Diagnostic Device Manufacturers : Manufacturers need Japan-specific market data to develop localized product strategies, understand regulatory requirements, and identify distribution partnerships within Japan's advanced healthcare ecosystem.
    • Healthcare Providers & Hospitals : Japanese hospitals and clinics require market insights to justify investment in latent TB testing infrastructure, benchmark against peers, and align procurement decisions with national TB elimination goals.
    • In Vitro Diagnostics (IVD) Companies : IVD firms need Japan market intelligence to assess commercial viability, understand reimbursement landscapes, and develop competitive positioning strategies for latent TB testing assays and platforms.
    • Healthcare Investors & Private Equity : Investment firms require Japan market data to evaluate acquisition targets, assess growth potential in the latent TB testing sector, and make informed capital allocation decisions in Japanese healthcare.
    • Government & Public Health Agencies : Japanese health ministries and public health organizations need market analysis to optimize TB screening program budgets, evaluate diagnostic technologies, and track progress toward TB elimination targets.

    Reasons to Buy this Report

    • Market-Specific Sizing & Forecasts : Access precise valuation data for Japan's latent TB testing market with detailed 2024-2029 projections, enabling accurate budget allocation and revenue forecasting for Japan-focused business strategies.
    • Demographic & Healthcare Insights : Understand Japan's unique aging population dynamics and advanced healthcare infrastructure that drive latent TB testing demand, informing product development and market entry strategies tailored to Japanese healthcare needs.
    • Competitive Positioning Analysis : Benchmark your organization against market trends specific to Japan, identifying growth opportunities within the 7.0% CAGR expansion and understanding regional competitive dynamics versus global markets.
    • Government Program Intelligence : Gain insights into Japan's TB elimination initiatives and national screening programs that create sustained demand, helping stakeholders align offerings with government priorities and reimbursement frameworks.
    • Strategic Market Entry Planning : Leverage Japan-specific market data to develop targeted go-to-market strategies, identify key healthcare stakeholders, and optimize resource allocation for successful market penetration in this high-growth segment.

    Frequently asked questions

    What is the current size of Japan's latent TB testing market?

    Japan's latent TB testing market was valued at $48.51 million in 2024 and is projected to grow to $68.15 million by 2029.

    What is the expected growth rate for latent TB testing in Japan?

    Japan's latent TB testing market is expected to grow at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.

    Which diagnostic methods are most commonly used for latent TB testing in Japan?

    In Japan, interferon-gamma release assays (IGRAs) and tuberculin skin tests (TSTs) are the primary diagnostic methods used for latent TB detection.

    What factors are driving growth in Japan's latent TB testing market?

    Japan's latent TB testing market growth is driven by an aging population, advanced healthcare infrastructure, occupational health screening requirements, and national TB elimination initiatives.

    Who are the primary end-users of latent TB testing services in Japan?

    Primary end-users in Japan include healthcare facilities, occupational health clinics, diagnostic laboratories, and public health agencies conducting TB screening programs.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the latent TB testing market. Exhaustive secondary research was done to collect information on the latent TB testing industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the latent TB testing market.

    The four steps involved in estimating the market size are

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

    Primary Research

    In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Primary sources were mainly industry experts from the core and related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information as well as assess prospects.

    The following is a breakdown of the primary respondents:

    Note 1: Others include sales managers, marketing managers, and product managers.

    Note 2: Companies are classified into tiers based on their total revenues. As of 2022/2023, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.

    To know about the assumptions considered for the study, download the pdf brochure

    COMPANY NAME DESIGNATION
    QIAGEN General Manager
    Revvity Area Sales Manager

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the latent TB testing market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    • The key players in the industry have been identified through extensive secondary research
    • The revenues generated by leading players operating in the latent TB testing market have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    The research methodology used to estimate the market size includes the following:

    Data Triangulation

    After arriving at the overall market size by applying the process mentioned above, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Latent tuberculosis testing refers to diagnosing the infection by detecting an immune response to Mycobacterium tuberculosis antigens using either the tuberculin skin test (TST) or interferon-gamma release assays (IGRAs). These tests help identify dormant tuberculosis infections in individuals without active symptoms.

    Stakeholders

    • Senior Management
    • End User
    • Finance/Procurement Department  
    • R&D Department

    Report Objectives

    • To define, describe, segment, and forecast the global latent TB testing market, by test type, application, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall latent TB testing market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
    • To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Middle East & Africa, and Latin America
    • To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
    • To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
    • To benchmark players within the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business and product excellence

     

    Get the Full Latent TB Testing Market Report

    Full forecast, segment splits, and company analysis for all Latent TB Testing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status